查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1285897

間質幹細胞市場（產品與服務：產品和服務；分離來源：骨髓、脂肪、臍帶血、外周血、牙髓及其他） - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢及預測

Mesenchymal Stem Cells Market (Products & Services: Product & Services; Source of Isolation: Bone Marrow, Adipose, Cord Blood, Peripheral Blood, Dental Pulp, & Others) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 237 Pages | 商品交期: 2-10個工作天內

價格

間充質幹細胞市場- 報告範圍

TMR關於全球間質幹細胞市場的報告研究了過去以及當前的成長趨勢和機會，以獲得對2023年至2031年預測期間市場指標的寶貴見解。報告提供了2017-2031年期間全球間質幹細胞市場的收入，考慮到2023年為基準年，2031年為預測年。報告還提供了2023年至2031年全球間質幹細胞市場的複合年成長率（CAGR %）。

該報告是在廣泛的研究後編寫的。一級研究涉及大部分的研究工作，其中分析師與關鍵意見領袖、行業領袖和意見製造者進行了訪談。二級研究包括參考主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解等離子體材料市場。

該報告深入研究了全球等離子體材料市場的競爭格局。在全球間質幹細胞市場運作的主要參與者已被確定，其中每一個都在各種屬性方面進行了分析。公司概況、財務狀況、最近的發展和SWOT是本報告中對全球間質幹細胞市場參與者的屬性描述。

目錄

第一章：前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 研究重點

第二章：假設和研究方法

第三章：執行摘要：全球市場

第四章：市場概述

  • 簡介
  • 概述
  • 市場動態
    • 驅動力
    • 限制因素
    • 機會
  • 2017-2031年全球市場分析與預測

第五章：關鍵洞察力

  • 管線分析
  • 參與研究的主要研究機構名單
  • 當前在各種疾病中的趨勢和未來前景
  • 各地區/全球的監管情況
  • COVID-19大流行對行業的影響

第六章：全球市場分析和預測：按產品和服務分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按產品和服務分類，2017-2031年
    • 產品
      • 工作流程類型
      • 產品類型
    • 服務
  • 市場吸引力分析：按產品和服務分類

第7章：全球市場分析和預測：按類型

  • 介紹和定義
  • 主要發現/發展
  • 市場價值預測：按類型，2017-2031年
    • 自體
    • 異源性
  • 市場吸引力分析：按類型分類

第八章：全球市場分析與預測：按分離源分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按分離源分類，2017-2031年
    • 骨髓
      • 脂肪
      • 臍帶血
      • 周邊血
    • 牙髓
    • 其他（肺組織、臍帶組織等）。
  • 市場吸引力分析：按分離來源分類

第九章：全球市場分析與預測：按適應症分類

  • 介紹和定義
  • 主要研究結果/發展情況
  • 市場價值預測：按適應症分類，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神經系統疾病
    • 自身免疫性疾病
    • 癌症
    • 遺傳性疾病
    • 肺部疾病
    • 其他疾病
  • 市場吸引力分析：按適應症

第十章：全球市場分析與預測：按地區分類

  • 主要研究結果
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第11章：北美洲市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品和服務，2017-2031年
    • 產品
      • 工作流程類型
      • 產品類型
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 自體
    • 異源性
  • 市場價值預測：按分離來源分類，2017-2031年
    • 骨髓
      • 脂肪
      • 臍帶血
      • 周邊血
    • 牙髓
    • 其他（肺組織、臍帶組織等）。
  • 市場價值預測：按適應症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神經疾病
    • 自身免疫性疾病
    • 癌症
    • 遺傳性疾病
    • 肺部疾病
    • 其他疾病
  • 市場價值預測：按國家分類，2017-2031年
    • 美國
    • 加拿大
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按分離源分類
    • 按適應症分類
    • 按國家分類

第十二章：歐洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品和服務，2017-2031年
    • 產品
      • 工作流程類型
      • 產品類型
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 自體
    • 異源性
  • 市場價值預測：按分離來源分類，2017-2031年
    • 骨髓
      • 脂肪
      • 臍帶血
      • 周邊血
    • 牙髓
    • 其他（肺組織、臍帶組織等）。
  • 市場價值預測：按適應症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神經疾病
    • 自身免疫性疾病
    • 癌症
    • 遺傳性疾病
    • 肺部疾病
    • 其他疾病
  • 市場價值預測：按國家/次區域，2017-2031年
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按分離源分類
    • 按適應症分類
    • 按國家/次區域分類

第13章：亞太地區市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品和服務，2017-2031年
    • 產品
      • 工作流程類型
      • 產品類型
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 自體
    • 異源性
  • 市場價值預測：按分離來源分類，2017-2031年
    • 骨髓
      • 脂肪
      • 臍帶血
      • 周邊血
    • 牙髓
    • 其他（肺組織、臍帶組織等）。
  • 市場價值預測：按適應症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神經疾病
    • 自身免疫性疾病
    • 癌症
    • 遺傳性疾病
    • 肺部疾病
    • 其他疾病
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 中國
    • 日本
    • 印度
    • 韓國
    • 亞太其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按隔離源分類
    • 按適應症分類
    • 按國家/次區域分類

第十四章：拉美市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品和服務，2017-2031年
    • 產品
      • 工作流程類型
      • 產品類型
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 自體
    • 異源性
  • 市場價值預測：按分離來源分類，2017-2031年
    • 骨髓
      • 脂肪
      • 臍帶血
      • 周邊血
    • 牙髓
    • 其他（肺組織、臍帶組織等）。
  • 市場價值預測：按適應症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神經疾病
    • 自身免疫性疾病
    • 癌症
    • 遺傳性疾病
    • 肺部疾病
    • 其他疾病
  • 市場價值預測：按國家/次區域，2017-2031年
    • 巴西
    • 墨西哥
    • 拉美其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按分離源分類
    • 按適應症分類
    • 按國家/次區域分類

第15章：中東和非洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按產品和服務，2017-2031年
    • 產品
      • 工作流程類型
      • 產品類型
    • 服務
  • 市場價值預測：按類型分類，2017-2031年
    • 自體
    • 異源性
  • 市場價值預測：按分離來源分類，2017-2031年
    • 骨髓
      • 脂肪
      • 臍帶血
      • 周邊血
    • 牙髓
    • 其他（肺組織、臍帶組織等）。
  • 市場價值預測：按適應症，2017-2031年
    • 肌肉骨骼疾病
    • 心血管疾病
    • 神經疾病
    • 自身免疫性疾病
    • 癌症
    • 遺傳性疾病
    • 肺部疾病
    • 其他疾病
  • 市場價值預測：按國家/次區域，2017-2031年
    • 海灣合作委員會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按產品分類
    • 按類型
    • 按隔離源分類
    • 按適應症分類
    • 按國家/次區域分類

第16章：競爭格局

  • 市場參與者- 競爭矩陣（按公司的層級和規模分類）
  • 市場佔有率分析：按公司分類，2021年
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Cytiva (Danaher Corporation)
    • FUJIFILM Irvine Scientific (FUJIFILM Corporation)
    • Merck KGaA
    • Lonza Group Ltd.
    • STEMCELL Technologies, Inc.
    • Takara Bio, Inc.
    • Sartorius AG
    • Miltenyi Biotec GmbH
    • PromoCell GmbH
Product Code: TMRGL26735

Mesenchymal Stem Cells Market - Scope of Report

TMR's report on the global Mesenchymal Stem Cells Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Mesenchymal Stem Cells Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Mesenchymal Stem Cells Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Mesenchymal Stem Cells market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Mesenchymal Stem Cells market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Mesenchymal Stem Cells market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Mesenchymal Stem Cells market.

The report delves into the competitive landscape of the global Mesenchymal Stem Cells market. Key players operating in the global Mesenchymal Stem Cells Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Mesenchymal Stem Cells Market profiled in this report.

Key Questions Answered in Global Mesenchymal Stem Cells Market Report:

  • What is the sales/revenue generated by Mesenchymal Stem Cells across all regions during the forecast period?
  • What are the opportunities in the global Mesenchymal Stem Cells market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Mesenchymal Stem Cells Market - Research Objectives and Research Approach

The comprehensive report on the global Mesenchymal Stem Cells Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Mesenchymal Stem Cells Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Mesenchymal Stem Cells market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mesenchymal Stem Cells Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Mesenchymal Stem Cells Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. List Of Major Research Institutes Involved In Mesenchymal Stem Cells Studies
  • 5.3. Mesenchymal Stem Cells: Current Trends and Future Prospects in a Variety of Disease Conditions
  • 5.4. Regulatory Scenario by Region/globally
  • 5.5. COVID-19 Pandemic Impact on Industry

6. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Products & Services

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Products & Services, 2017-2031
    • 6.3.1. Product
      • 6.3.1.1. Workflow Type
      • 6.3.1.2. Product Type
    • 6.3.2. Services
  • 6.4. Market Attractiveness Analysis, by Products & Services

7. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Type, 2017-2031
    • 7.3.1. Autologous
    • 7.3.2. Allogenic
  • 7.4. Market Attractiveness Analysis, by Type

8. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Source of Isolation

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Source of Isolation, 2017-2031
    • 8.3.1. Bone Marrow
      • 8.3.1.1. Adipose
      • 8.3.1.2. Cord Blood
      • 8.3.1.3. Peripheral Blood
    • 8.3.2. Dental Pulp
    • 8.3.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 8.4. Market Attractiveness Analysis, by Source of Isolation

9. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Indication

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by Indication, 2017-2031
    • 9.3.1. Musculoskeletal Diseases
    • 9.3.2. Cardiovascular Diseases
    • 9.3.3. Neuro Disorders
    • 9.3.4. Autoimmune Diseases
    • 9.3.5. Cancer
    • 9.3.6. GvHD
    • 9.3.7. Pulmonary Diseases
    • 9.3.8. Others
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Mesenchymal Stem Cells Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Mesenchymal Stem Cells Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Products & Services, 2017-2031
    • 11.2.1. Product
      • 11.2.1.1. Workflow Type
      • 11.2.1.2. Product Type
    • 11.2.2. Services
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. Autologous
    • 11.3.2. Allogenic
  • 11.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 11.4.1. Bone Marrow
      • 11.4.1.1. Adipose
      • 11.4.1.2. Cord Blood
      • 11.4.1.3. Peripheral Blood
    • 11.4.2. Dental Pulp
    • 11.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 11.5. Market Value Forecast, by Indication , 2017-2031
    • 11.5.1. Musculoskeletal Diseases
    • 11.5.2. Cardiovascular Diseases
    • 11.5.3. Neuro Disorders
    • 11.5.4. Autoimmune Diseases
    • 11.5.5. Cancer
    • 11.5.6. GvHD
    • 11.5.7. Pulmonary Diseases
    • 11.5.8. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Type
    • 11.7.3. By Source of Isolation
    • 11.7.4. By Indication
    • 11.7.5. By Country

12. Europe Mesenchymal Stem Cells Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Products & Services, 2017-2031
    • 12.2.1. Product
      • 12.2.1.1. Workflow Type
      • 12.2.1.2. Product Type
    • 12.2.2. Services
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. Autologous
    • 12.3.2. Allogenic
  • 12.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 12.4.1. Bone Marrow
      • 12.4.1.1. Adipose
      • 12.4.1.2. Cord Blood
      • 12.4.1.3. Peripheral Blood
    • 12.4.2. Dental Pulp
    • 12.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 12.5. Market Value Forecast, by Indication , 2017-2031
    • 12.5.1. Musculoskeletal Diseases
    • 12.5.2. Cardiovascular Diseases
    • 12.5.3. Neuro Disorders
    • 12.5.4. Autoimmune Diseases
    • 12.5.5. Cancer
    • 12.5.6. GvHD
    • 12.5.7. Pulmonary Diseases
    • 12.5.8. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Type
    • 12.7.3. By Source of Isolation
    • 12.7.4. By Indication
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Mesenchymal Stem Cells Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Products & Services, 2017-2031
    • 13.2.1. Product
      • 13.2.1.1. Workflow Type
      • 13.2.1.2. Product Type
    • 13.2.2. Services
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. Autologous
    • 13.3.2. Allogenic
  • 13.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 13.4.1. Bone Marrow
      • 13.4.1.1. Adipose
      • 13.4.1.2. Cord Blood
      • 13.4.1.3. Peripheral Blood
    • 13.4.2. Dental Pulp
    • 13.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 13.5. Market Value Forecast, by Indication , 2017-2031
    • 13.5.1. Musculoskeletal Diseases
    • 13.5.2. Cardiovascular Diseases
    • 13.5.3. Neuro Disorders
    • 13.5.4. Autoimmune Diseases
    • 13.5.5. Cancer
    • 13.5.6. GvHD
    • 13.5.7. Pulmonary Diseases
    • 13.5.8. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. South Korea
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Type
    • 13.7.3. By Source of Isolation
    • 13.7.4. By Indication
    • 13.7.5. By Country/Sub-region

14. Latin America Mesenchymal Stem Cells Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Products & Services, 2017-2031
    • 14.2.1. Product
      • 14.2.1.1. Workflow Type
      • 14.2.1.2. Product Type
    • 14.2.2. Services
  • 14.3. Market Value Forecast, by Type, 2017-2031
    • 14.3.1. Autologous
    • 14.3.2. Allogenic
  • 14.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 14.4.1. Bone Marrow
      • 14.4.1.1. Adipose
      • 14.4.1.2. Cord Blood
      • 14.4.1.3. Peripheral Blood
    • 14.4.2. Dental Pulp
    • 14.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 14.5. Market Value Forecast, by Indication , 2017-2031
    • 14.5.1. Musculoskeletal Diseases
    • 14.5.2. Cardiovascular Diseases
    • 14.5.3. Neuro Disorders
    • 14.5.4. Autoimmune Diseases
    • 14.5.5. Cancer
    • 14.5.6. GvHD
    • 14.5.7. Pulmonary Diseases
    • 14.5.8. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Type
    • 14.7.3. By Source of Isolation
    • 14.7.4. By Indication
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Mesenchymal Stem Cells Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Products & Services, 2017-2031
    • 15.2.1. Product
      • 15.2.1.1. Workflow Type
      • 15.2.1.2. Product Type
    • 15.2.2. Services
  • 15.3. Market Value Forecast, by Type, 2017-2031
    • 15.3.1. Autologous
    • 15.3.2. Allogenic
  • 15.4. Market Value Forecast, by Source of Isolation, 2017-2031
    • 15.4.1. Bone Marrow
      • 15.4.1.1. Adipose
      • 15.4.1.2. Cord Blood
      • 15.4.1.3. Peripheral Blood
    • 15.4.2. Dental Pulp
    • 15.4.3. Others (lung tissue, umbilical cord tissue, etc.)
  • 15.5. Market Value Forecast, by Indication, 2017-2031
    • 15.5.1. Musculoskeletal Diseases
    • 15.5.2. Cardiovascular Diseases
    • 15.5.3. Neuro Disorders
    • 15.5.4. Autoimmune Diseases
    • 15.5.5. Cancer
    • 15.5.6. GvHD
    • 15.5.7. Pulmonary Diseases
    • 15.5.8. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Type
    • 15.7.3. By Source of Isolation
    • 15.7.4. By Indication
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company, 2021
  • 16.3. Company Profiles
    • 16.3.1. Thermo Fisher Scientific, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Cytiva (Danaher Corporation)
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. FUJIFILM Irvine Scientific (FUJIFILM Corporation)
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck KGaA
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Lonza Group Ltd.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. STEMCELL Technologies, Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Takara Bio, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Sartorius AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Miltenyi Biotec GmbH
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. PromoCell GmbH
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 02: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 03: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 04: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2032
  • Table 05: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 06: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Region, 2017-2032
  • Table 07: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country, 2017-2032
  • Table 08: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 09: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 10: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 11: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 12: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 13: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 14: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 15: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 16: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 17: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 18: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 19: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 20: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 21: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 22: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 23: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 24: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 25: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 26: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 27: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 28: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 29: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 30: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032
  • Table 31: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2032
  • Table 32: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Products & Services, 2017-2032
  • Table 33: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Product, 2017-2032
  • Table 34: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Type, 2017-2032
  • Table 35: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Source of Isolation, 2017-2031
  • Table 36: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, by Indication, 2017-2032

List of Figures

  • Figure 01: Global Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 02: Global Mesenchymal Stem Cells Market Value Share, by Products & Services, 2022
  • Figure 03: Global Mesenchymal Stem Cells Market Value Share, by Type, 2022
  • Figure 04: Global Mesenchymal Stem Cells Market Value Share, by Source of Isolation, 2022
  • Figure 05: Global Mesenchymal Stem Cells Market Value Share, by Indication, 2022
  • Figure 06: Global Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 07: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 08: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Product, 2017-2032
  • Figure 09: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Services, 2017-2032
  • Figure 10: Global Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 11: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 12: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Autologous, 2017-2032
  • Figure 13: Global Mesenchymal Stem Cells Market Revenue (US$ Mn), by Allogenic, 2017-2032
  • Figure 14: Global Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 15: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 16: Global Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 17: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023-2032
  • Figure 18: Global Mesenchymal Stem Cells Market Value Share Analysis, by Region, 2022 and 2032
  • Figure 19: Global Mesenchymal Stem Cells Market Attractiveness Analysis, by Region, 2023-2032
  • Figure 20: North America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 21: North America Mesenchymal Stem Cells Market Value Share Analysis, by Country, 2022 and 2032
  • Figure 22: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country, 2023-2032
  • Figure 23: North America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 24: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 25: North America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 26: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 27: North America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 28: North America Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 29: North America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 30: North America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 31: Europe Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 32: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 33: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 34: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 35: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 36: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 37: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 38: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 39: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 40: Europe Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 41: Europe Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 42: Asia Pacific Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 43: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 44: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 45: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 46: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 47: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 48: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 49: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 50: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation 2023-2032
  • Figure 51: Asia Pacific Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 52: Asia Pacific Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 53: Latin America Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 54: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 55: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 56: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 57: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 58: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 59: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Type, 2023-2032
  • Figure 60: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 61: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Source of Isolation, 2023-2032
  • Figure 62: Latin America Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 63: Latin America Mesenchymal Stem Cells Market Attractiveness Analysis, Indication, 2023-2032
  • Figure 64: Middle East & Africa Mesenchymal Stem Cells Market Value (US$ Mn) Forecast, 2017-2032
  • Figure 65: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Country/Sub-region, 2022 and 2032
  • Figure 66: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Country/Sub-region, 2023-2032
  • Figure 67: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Products & Services, 2022 and 2032
  • Figure 68: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Products & Services, 2023-2032
  • Figure 69: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Type, 2022 and 2032
  • Figure 70: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Type, 2023-2032
  • Figure 71: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Source of Isolation, 2022 and 2032
  • Figure 72: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Source of Isolation, 2023-2032
  • Figure 73: Middle East & Africa Mesenchymal Stem Cells Market Value Share Analysis, by Indication, 2022 and 2032
  • Figure 74: Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Analysis, by Indication, 2023-2032